Market Overview:
The global medical device analytical testing outsourcing market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for medical devices and rising number of regulatory approvals for these devices. In addition, the growing focus on quality control and safety by manufacturers is also propelling the growth of this market. Based on type, the extractable & leachable segment is expected to account for the largest share of the global medical device analytical testing outsourcing market in 2018. This segment is mainly driven by stringent regulatory requirements related to extractables & leachables in various regions across the globe.
Product Definition:
Medical device analytical testing outsourcing is the process of sending medical device samples to an external laboratory for analysis. This process can be used to test the quality and safety of medical devices, as well as to verify that they meet regulatory requirements. By outsourcing this type of testing, manufacturers can save time and money, while also ensuring that their products are compliant with safety regulations.
Extractable & Leachable:
Extractable & leachable is a term used in the field of analytical testing for medical devices. It is used to express the amount of extractable and leachable substances from a device under test conditions. The two terms are often confused, but they have distinct functions.
Material Charecterization:
Material characterization is the process of determining and analyzing the chemical and physical properties of a material. It includes determination of phase diagrams, heat transfer, viscosity, density, surface area etc. for different types of materials used in medical device analytical testing outsourcing market such as polymers & resins (plastics), ceramics & metals and fluids (lubricants).
Application Insights:
The large enterprise segment dominated the global medical device analytical testing outsourcing market in 2017. This can be attributed to factors such as larger revenue share of the healthcare sector and presence of a strong base of traditional players. Furthermore, increasing penetration and demand for point-of-care analyzers are expected to drive growth over the forecast period.
Small & medium enterprises (SMEs) accounted for a significant share in 2017 owing to rising penetration and adoption of point-of-care analyzers by SMEs due to their low cost, ease of use, compact size, and availability at reasonable prices. In addition, these devices offer real time results that help avoid laboratory errors resulting from improper specimen processing or test design flaws that may have affected other parts of the world; this factor is expected to further fuel industry expansion over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to factors such as favorable government initiatives, increasing R&D activities, and high healthcare expenditure in this region. In addition, rising number of outsourcing centers in North America supports regional growth. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to presence of untapped opportunities and rapidly improving healthcare infrastructure & standards across countries such as India & China & Singapore among others which are prime destinations for medical device analytical testing outsourcing services providers due to low labor cost and availability of skilled professionals with good English language skills at competitive rates along with a large customer base from various sectors including manufacturing, pharmaceuticals etc.
Growth Factors:
- Increasing demand for medical devices due to rising incidence of lifestyle diseases
- Growing number of medical device manufacturers and suppliers
- Rising demand for contract research and development services in the medical device industry
- Proliferation of new technologies in the medical device sector
- Increasing focus on quality by regulatory authorities
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Device Analytical Testing Outsourcing Market Research Report
By Type
Extractable & Leachable, Material Charecterization, Physical Testing, Bioburden Testing, Sterility Testing, Others
By Application
Small & Medium Enterprise, Large Enterprise
By Companies
SGS SA (Switzerland), Toxikon, Inc. (US), Eurofins Scientific (Luxembourg), Pace Analytical Services, LLC (US), Intertek Group plc (UK), WuXi AppTec. (China), NORTH AMERICAN SCIENCE ASSOCIATES INC. (US), Envigo (UK), Charles River Laboratories International Inc. (US), Medical Device Testing Services (US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
161
Number of Tables & Figures
113
Customization Available
Yes, the report can be customized as per your need.
Global Medical Device Analytical Testing Outsourcing Market Report Segments:
The global Medical Device Analytical Testing Outsourcing market is segmented on the basis of:
Types
Extractable & Leachable, Material Charecterization, Physical Testing, Bioburden Testing, Sterility Testing, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Small & Medium Enterprise, Large Enterprise
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SGS SA (Switzerland)
- Toxikon, Inc. (US)
- Eurofins Scientific (Luxembourg)
- Pace Analytical Services, LLC (US)
- Intertek Group plc (UK)
- WuXi AppTec. (China)
- NORTH AMERICAN SCIENCE ASSOCIATES INC. (US)
- Envigo (UK)
- Charles River Laboratories International Inc. (US)
- Medical Device Testing Services (US)
Highlights of The Medical Device Analytical Testing Outsourcing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Extractable & Leachable
- Material Charecterization
- Physical Testing
- Bioburden Testing
- Sterility Testing
- Others
- By Application:
- Small & Medium Enterprise
- Large Enterprise
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Device Analytical Testing Outsourcing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical Device Analytical Testing Outsourcing is the process of contracting with a third-party laboratory to perform analytical testing on medical devices. This service can be beneficial for companies who need to ensure that their products are compliant with regulatory requirements, or who want to outsource the time-consuming and costly task of performing device testing themselves.
Some of the key players operating in the medical device analytical testing outsourcing market are SGS SA (Switzerland), Toxikon, Inc. (US), Eurofins Scientific (Luxembourg), Pace Analytical Services, LLC (US), Intertek Group plc (UK), WuXi AppTec. (China), NORTH AMERICAN SCIENCE ASSOCIATES INC. (US), Envigo (UK), Charles River Laboratories International Inc. (US), Medical Device Testing Services (US).
The medical device analytical testing outsourcing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Device Analytical Testing Outsourcing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical Device Analytical Testing Outsourcing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical Device Analytical Testing Outsourcing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical Device Analytical Testing Outsourcing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical Device Analytical Testing Outsourcing Market Size & Forecast, 2018-2028
4.5.1 Medical Device Analytical Testing Outsourcing Market Size and Y-o-Y Growth
4.5.2 Medical Device Analytical Testing Outsourcing Market Absolute $ Opportunity
Chapter 5 Global Medical Device Analytical Testing Outsourcing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Medical Device Analytical Testing Outsourcing Market Size Forecast by Type
5.2.1 Extractable & Leachable
5.2.2 Material Charecterization
5.2.3 Physical Testing
5.2.4 Bioburden Testing
5.2.5 Sterility Testing
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Medical Device Analytical Testing Outsourcing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Medical Device Analytical Testing Outsourcing Market Size Forecast by Applications
6.2.1 Small & Medium Enterprise
6.2.2 Large Enterprise
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Device Analytical Testing Outsourcing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Device Analytical Testing Outsourcing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Medical Device Analytical Testing Outsourcing Analysis and Forecast
9.1 Introduction
9.2 North America Medical Device Analytical Testing Outsourcing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Medical Device Analytical Testing Outsourcing Market Size Forecast by Type
9.6.1 Extractable & Leachable
9.6.2 Material Charecterization
9.6.3 Physical Testing
9.6.4 Bioburden Testing
9.6.5 Sterility Testing
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Medical Device Analytical Testing Outsourcing Market Size Forecast by Applications
9.10.1 Small & Medium Enterprise
9.10.2 Large Enterprise
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Medical Device Analytical Testing Outsourcing Analysis and Forecast
10.1 Introduction
10.2 Europe Medical Device Analytical Testing Outsourcing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Medical Device Analytical Testing Outsourcing Market Size Forecast by Type
10.6.1 Extractable & Leachable
10.6.2 Material Charecterization
10.6.3 Physical Testing
10.6.4 Bioburden Testing
10.6.5 Sterility Testing
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Medical Device Analytical Testing Outsourcing Market Size Forecast by Applications
10.10.1 Small & Medium Enterprise
10.10.2 Large Enterprise
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Medical Device Analytical Testing Outsourcing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Medical Device Analytical Testing Outsourcing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Medical Device Analytical Testing Outsourcing Market Size Forecast by Type
11.6.1 Extractable & Leachable
11.6.2 Material Charecterization
11.6.3 Physical Testing
11.6.4 Bioburden Testing
11.6.5 Sterility Testing
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Medical Device Analytical Testing Outsourcing Market Size Forecast by Applications
11.10.1 Small & Medium Enterprise
11.10.2 Large Enterprise
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Medical Device Analytical Testing Outsourcing Analysis and Forecast
12.1 Introduction
12.2 Latin America Medical Device Analytical Testing Outsourcing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Medical Device Analytical Testing Outsourcing Market Size Forecast by Type
12.6.1 Extractable & Leachable
12.6.2 Material Charecterization
12.6.3 Physical Testing
12.6.4 Bioburden Testing
12.6.5 Sterility Testing
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Medical Device Analytical Testing Outsourcing Market Size Forecast by Applications
12.10.1 Small & Medium Enterprise
12.10.2 Large Enterprise
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Medical Device Analytical Testing Outsourcing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Medical Device Analytical Testing Outsourcing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Medical Device Analytical Testing Outsourcing Market Size Forecast by Type
13.6.1 Extractable & Leachable
13.6.2 Material Charecterization
13.6.3 Physical Testing
13.6.4 Bioburden Testing
13.6.5 Sterility Testing
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Medical Device Analytical Testing Outsourcing Market Size Forecast by Applications
13.10.1 Small & Medium Enterprise
13.10.2 Large Enterprise
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Device Analytical Testing Outsourcing Market: Competitive Dashboard
14.2 Global Medical Device Analytical Testing Outsourcing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 SGS SA (Switzerland)
14.3.2 Toxikon, Inc. (US)
14.3.3 Eurofins Scientific (Luxembourg)
14.3.4 Pace Analytical Services, LLC (US)
14.3.5 Intertek Group plc (UK)
14.3.6 WuXi AppTec. (China)
14.3.7 NORTH AMERICAN SCIENCE ASSOCIATES INC. (US)
14.3.8 Envigo (UK)
14.3.9 Charles River Laboratories International Inc. (US)
14.3.10 Medical Device Testing Services (US)
